| Recruiting | Variability of Microwave Ablation Volume Based on Clinical, Radiological, Biological, and Tissue Factors NCT07413640 | Central Hospital, Nancy, France | — |
| Recruiting | Y-90 Treatment Response Using Transarterial Radioembolization NCT07145801 | Thomas Jefferson University | Phase 2 |
| Recruiting | Prediction Model for MINS After Major Hepatobiliary Surgery NCT07335042 | Beijing Tsinghua Chang Gung Hospital | — |
| Recruiting | DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases NCT06555003 | Tehran University of Medical Sciences | Phase 3 |
| Completed | SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA NCT05848947 | Sirtex Medical | Phase 4 |
| Unknown | Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT) NCT05723705 | Amsterdam UMC, location VUmc | — |
| Recruiting | Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease NCT07265544 | Nanfang Hospital, Southern Medical University | — |
| Recruiting | Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy NCT05169177 | University of Sydney | — |
| Recruiting | T-Cell Therapy (ECT204) in Adults With Advanced HCC NCT04864054 | Eureka Therapeutics Inc. | Phase 1 / Phase 2 |
| Completed | Perioperative Myocardial and Renal Injury in Patients Undergoing Hepatic Resection NCT06775158 | Istanbul Saglik Bilimleri University | — |
| Terminated | Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) NCT04502082 | Eureka Therapeutics Inc. | Phase 1 |
| Terminated | Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections NCT04187937 | Insel Gruppe AG, University Hospital Bern | N/A |
| Unknown | Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors NCT04010071 | Peking Union Medical College Hospital | Phase 2 |
| Terminated | Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma NCT03998033 | Eureka Therapeutics Inc. | Phase 1 |
| Unknown | Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liv NCT03803436 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Terminated | Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolizati NCT04702230 | University of Zurich | — |
| Unknown | Efficacy and Safety of a Preoperative Aerobic Exercise Program in Patients With Gastrointestinal Cancer. NCT03423056 | Instituto Nacional de Cancerologia, Columbia | N/A |
| Unknown | Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial NCT02632864 | Samsung Medical Center | Phase 2 |
| Withdrawn | Gut Microbiota in People With Hepatocellular Carcinoma (HCC) NCT02599909 | National Cancer Institute (NCI) | — |
| Completed | Mobilization of Mesenchymal Stem Cells During Liver Transplantation NCT02557724 | Rutgers, The State University of New Jersey | — |
| Completed | Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis NCT02571946 | Samsung Medical Center | N/A |
| Completed | Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization NCT02471313 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors NCT05495529 | Centre Hospitalier Universitaire de Nice | — |
| Unknown | Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer NCT01542281 | McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| Unknown | Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib NCT01217034 | Kindai University | Phase 2 |
| Unknown | Effectiveness of Routine Application Of Anterior Approach During Right Hepatectomy NCT01180088 | Azienda Ospedaliera Ordine Mauriziano di Torino | N/A |
| Withdrawn | Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary L NCT00510627 | Boston Scientific Corporation | Phase 4 |
| Completed | A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic NCT00001576 | National Cancer Institute (NCI) | Phase 1 |
| Approved For Marketing | TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma NCT00906984 | University of California, Irvine | — |
| Completed | Estimation of Functional Liver Reserve Using Cholinesterases NCT00883454 | University of Milan | — |